Exploring the serum proteome in dogs: Setting the scene for the discovery of new biomarkers in canine lymphoma

Veterinary Journal

Volumn 196, Issue 3, 2013, Pages 286-287

  Mobasheri, Ali ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; HAPTOGLOBIN; PROTEOME; SURVIVIN; TUMOR MARKER;

CANCER INCIDENCE; CANCER MORTALITY; DOG DISEASE; EDITORIAL; ENVIRONMENTAL FACTOR; LARGE CELL LYMPHOMA; LYMPHOMA; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RISK FACTOR; TANDEM MASS SPECTROMETRY;

ANIMALS; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MASS SPECTROMETRY; PROTEOME; TRANSCRIPTOME;

CANIS FAMILIARIS;

EID: 84879412335     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.01.006     Document Type: Editorial

References (32)

1. Atherton M.J., Braceland M., Harvie J., Burchmore R.J., Eadie S., Eckersall P.D., Morris J.S. Characterisation of the normal canine serum proteome with a novel electrophoretic technique combined with mass spectrometry. The Veterinary Journal 2013, 196:315-319.
2. Atherton M.J., Braceland M., Fontaine S., Waterston M.M., Burchmore R.J., Eadie S., Eckersall P.D., Morris J.S. Changes in the serum proteome of canine lymphoma identified by electrophoresis and mass spectrometry. The Veterinary Journal 2013, 196:320-324.
3. Bloom F., Meyer L.M. Malignant lymphoma (so-called leukemia) in dogs. American Journal of Pathology 1945, 21:683-715.
4. Boyd R.S., Dyer M.J., Cain K. Proteomic analysis of B-cell malignancies. Journal of Proteomics 2010, 73:1804-1822.
5. Cotchin E. Spontaneous tumours in young animals. Proceedings of the Royal Society of Medicine 1975, 68:653-655.
6. Djeu J.Y., Wei S. Clusterin and chemoresistance. Advances in Cancer Research 2009, 105:77-92.
7. Gaines P.J., Powell T.D., Walmsley S.J., Estredge K.L., Wisnewski N., Stinchcomb D.T., Withrow S.J., Lana S.E. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. American Journal of Veterinary Research 2007, 68:405-410.
8. Gordon I., Paoloni M., Mazcko C., Khanna C. The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Medicine 2009, 6:e1000161.
9. Kanwar J.R., Kamalapuram S.K., Kanwar R.K. Survivin signaling in clinical oncology: A multifaceted dragon. Medicinal Research Reviews 2012, 10.1002/med.21264.
10. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J.F., Niemi S., Comstock K.E., Ostrander E., Westmoreland S., Withrow S. The dog as a cancer model. Nature Biotechnology 2006, 24:1065-1066.
11. Leroy B.E., Northrup N. Prostate cancer in dogs: Comparative and clinical aspects. The Veterinary Journal 2009, 180:149-162.
12. MacEwen E.G. Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer and Metastasis Reviews 1990, 9:125-136.
13. McCaw D.L., Chan A.S., Stegner A.L., Mooney B., Bryan J.N., Turnquist S.E., Henry C.J., Alexander H., Alexander S. Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clinical Cancer Research 2007, 13:2496-2503.
14. Misdorp W. Veterinary cancer epidemiology. Veterinary Quarterly 1996, 18:32-36.
15. Mueller F., Fuchs B., Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Research 2007, 27:155-164.
16. Nakayama K., Kamihira S. Survivin an important determinant for prognosis in adult T-cell leukemia: A novel biomarker in practical hemato-oncology. Leukemia and Lymphoma 2002, 43:2249-2255.
17. Olsen S.H., Ma L., Schnitzer B., Fullen D.R. Clusterin expression in cutaneous CD30-positive lymphoproliferative disorders and their histologic simulants. Journal of Cutaneous Pathology 2009, 36:302-307.
18. Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer 2008, 8:147-156.
19. Pieper R., Gatlin C.L., Makusky A.J., Russo P.S., Schatz C.R., Miller S.S., Su Q., McGrath A.M., Estock M.A., Parmar P.P., Zhao M., Huang S.T., Zhou J., Wang F., Esquer-Blasco R., Anderson N.L., Taylor J., Steiner S. The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003, 3:1345-1364.
20. Ratcliffe L., Mian S., Slater K., King H., Napolitano M., Aucoin D., Mobasheri A. Proteomic identification and profiling of canine lymphoma patients. Veterinary and Comparative Oncology 2009, 7:92-105.
21. Rebhun R.B., Lana S.E., Ehrhart E.J., Charles J.B., Thamm D.H. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. Journal of Veterinary Internal Medicine 2008, 22:989-995.
22. Rodel F., Sprenger T., Kaina B., Liersch T., Rodel C., Fulda S., Hehlgans S. Survivin as a prognostic/predictive marker and molecular target in cancer therapy. Current Medicinal Chemistry 2012, 19:3679-3688.
23. Rowell J.L., McCarthy D.O., Alvarez C.E. Dog models of naturally occurring cancer. Trends in Molecular Medicine 2011, 17:380-388.
24. Selvarajah G.T., Kirpensteijn J. Prognostic and predictive biomarkers of canine osteosarcoma. The Veterinary Journal 2010, 185:28-35.
25. Selvarajah G.T., Kirpensteijn J., van Wolferen M.E., Rao N.A., Fieten H., Mol J.A. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Molecular Cancer 2009, 8:72.
26. Trougakos I.P., Lourda M., Antonelou M.H., Kletsas D., Gorgoulis V.G., Papassideri I.S., Zou Y., Margaritis L.H., Boothman D.A., Gonos E.S. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clinical Cancer Research 2009, 15:48-59.
27. Tuck M.K., Chan D.W., Chia D., Godwin A.K., Grizzle W.E., Krueger K.E., Rom W., Sanda M., Sorbara L., Stass S., Wang W., Brenner D.E. Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group. Journal of Proteome Research 2009, 8:113-117.
28. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 2000, 18:781-792.
29. Wei L., Xue T., Wang J., Chen B., Lei Y., Huang Y., Wang H., Xin X. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. International Journal of Cancer 2009, 125:791-806.
30. Withrow S.J., Powers B.E., Straw R.C., Wilkins R.M. Comparative aspects of osteosarcoma. Dog versus man. Clinical Orthopaedics and Related Research 1991, 270:159-168.
31. Yue Z., Carvalho A., Xu Z., Yuan X., Cardinale S., Ribeiro S., Lai F., Ogawa H., Gudmundsdottir E., Gassmann R., Morrison C.G., Ruchaud S., Earnshaw W.C. Deconstructing survivin: Comprehensive genetic analysis of survivin function by conditional knockout in a vertebrate cell line. Journal of Cell Biology 2008, 183:279-296.
32. Zoubeidi A., Gleave M. Small heat shock proteins in cancer therapy and prognosis. International Journal of Biochemistry and Cell Biology 2012, 44:1646-1656.